Episodes
3
Sept. 30, 2019
Diabetes 360: Season 3, Episode 3
Dr. Michael Brent is a clinician scientist who specializes in diabetic retinopathy and age-related macular degeneration. Through his research work for Diabetes Action Canada, he is leading a team of Canadian eye health experts on the development of a national diabetic retinopathy screening program for Canadians living with diabetes. In this episode, Dr. Brent discusses diabetic retinopathy and ways patients can work with their healthcare team for successful eye health outcomes.
3
Sept. 30, 2019
Diabetes 360: Season 3, Episode 3
Dr. Michael Brent is a clinician scientist who specializes in diabetic retinopathy and age-related macular degeneration. Through his research work for Diabetes Action Canada, he is leading a team of
3
Sept. 30, 2019
Diabetes 360: Season 3, Episode 3
Dr. Michael Brent is a clinician scientist who specializes in diabetic retinopathy and age-related macular degeneration. Through his research work for Diabetes Action Canada, he is leading a team of Canadian eye health experts on the development of a national diabetic retinopathy screening program for Canadians living with diabetes. In this episode, Dr. Brent discusses diabetic retinopathy and ways patients can work with their healthcare team for successful eye health outcomes.
3
Sept. 30, 2019
Diabetes 360: Season 3, Episode 3
Dr. Michael Brent is a clinician scientist who specializes in diabetic retinopathy and age-related macular degeneration. Through his research work for Diabetes Action Canada, he is leading a team of
2
Sept. 16, 2019
Diabetes 360: Season 3, Episode 2
Can where you live determine your chances of developing type 2 diabetes? And how much impact does your income or living circumstances play into this risk? Dr. Gillian Booth discusses her work on the social determinants of health and diabetes. Dr. Booth is an endocrinologist and a scientist at the Centre for Urban Health Solutions at St. Michael’s Hospital in Toronto. Dr. Booth will be a plenary speaker at the 2019 Diabetes Canada Professional Conference, which is taking place in Winnipeg this O...
2
Sept. 16, 2019
Diabetes 360: Season 3, Episode 2
Can where you live determine your chances of developing type 2 diabetes? And how much impact does your income or living circumstances play into this risk? Dr. Gillian Booth discusses her work on the
2
Sept. 16, 2019
Diabetes 360: Season 3, Episode 2
Can where you live determine your chances of developing type 2 diabetes? And how much impact does your income or living circumstances play into this risk? Dr. Gillian Booth discusses her work on the social determinants of health and diabetes. Dr. Booth is an endocrinologist and a scientist at the Centre for Urban Health Solutions at St. Michael’s Hospital in Toronto. Dr. Booth will be a plenary speaker at the 2019 Diabetes Canada Professional Conference, which is taking place in Winnipeg this O...
2
Sept. 16, 2019
Diabetes 360: Season 3, Episode 2
Can where you live determine your chances of developing type 2 diabetes? And how much impact does your income or living circumstances play into this risk? Dr. Gillian Booth discusses her work on the
1
Sept. 3, 2019
Diabetes 360: Season 3, Episode 1
Dr. Bruce Perkins from the University of Toronto and Mount Sinai Hospital studies the complications of diabetes and ways to improve treatment for those living with type 1 diabetes. At the 2019 Diabetes Canada Professional Conference, taking place this October in Winnipeg, he’ll be delivering a plenary address on his work in adjunctive therapies for type 1 diabetes. This talk will focus on the use of Sodium Glucose Transport Inhibitors (SGLTis) in the treatment of T1D. These drugs have been trans...
1
Sept. 3, 2019
Diabetes 360: Season 3, Episode 1
Dr. Bruce Perkins from the University of Toronto and Mount Sinai Hospital studies the complications of diabetes and ways to improve treatment for those living with type 1 diabetes. At the 2019 Diabete
1
Sept. 3, 2019
Diabetes 360: Season 3, Episode 1
Dr. Bruce Perkins from the University of Toronto and Mount Sinai Hospital studies the complications of diabetes and ways to improve treatment for those living with type 1 diabetes. At the 2019 Diabetes Canada Professional Conference, taking place this October in Winnipeg, he’ll be delivering a plenary address on his work in adjunctive therapies for type 1 diabetes. This talk will focus on the use of Sodium Glucose Transport Inhibitors (SGLTis) in the treatment of T1D. These drugs have been trans...
1
Sept. 3, 2019
Diabetes 360: Season 3, Episode 1
Dr. Bruce Perkins from the University of Toronto and Mount Sinai Hospital studies the complications of diabetes and ways to improve treatment for those living with type 1 diabetes. At the 2019 Diabete